Patents by Inventor Gary Peter Martin

Gary Peter Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100236550
    Abstract: An inhalable dry powder medicament is provided. The medicament, which provides improved fine particle fraction, may be prepared by (i) fractionating a particulate active ingredient based on aerodynamic particle size, (ii) recovering at least one fraction of the particulate active ingredient and (iii) combining the recovered fraction with a carrier to provide the inhalable dry powder medicament.
    Type: Application
    Filed: July 18, 2008
    Publication date: September 23, 2010
    Applicant: NORTON HEALTHCARE LTD.
    Inventors: Xian-Ming Zeng, Gary Peter Martin, Christoper Marriott, Mohammed Taki
  • Patent number: 6890901
    Abstract: Pharmaceutical compositions comprising a mixture of hyaluronic acid and liposomes. Preferably, the pharmaceutical compositions further include a pharmaceutically active substance such as cyclosporin A encapsulated in the liposomes. A method for preparing a pharmaceutical composition includes producing liposomes from phospholipids, preferably in the presence of a pharmaceutically active substance (most preferably cyclosporin A) to be encapsulated within the liposomes, and mixing the liposomes with hyaluronic acid. Pharmaceutical compositions of this invention are used, for example, to topically administer pharmaceutical agents effective to treat skin disorders by deposition of that agent in the dermis or sub-dermis while minimizing systemic circulation thereof. These compositions are also administered orally, parenterally and intrarectally.
    Type: Grant
    Filed: September 29, 1997
    Date of Patent: May 10, 2005
    Assignee: Jagotec AG
    Inventors: Christopher Marriott, Gary Peter Martin, Marc Barry Brown
  • Patent number: 6875449
    Abstract: A process for the production of crystals with controlled surface smoothness, size, shape and degree of crystallinity, compositions comprising such crystals, and the use of certain crystals, especially lactose, lactose monohydrate, fluticasone propionate, salmeterol xinafoate, salbutamol sulphate or ipratropium bromide in pharmaceutical compositions.
    Type: Grant
    Filed: March 24, 1999
    Date of Patent: April 5, 2005
    Assignee: Glaxo Wellcome, Inc.
    Inventors: Christopher Marriott, Gary Peter Martin, Xian-Ming Zeng
  • Publication number: 20030152523
    Abstract: A dry particulate pharmaceutical composition for pulmonary administration is prepared by spray-drying a hydrophobic active agent (e.g. declomethasone dipropionate) with a small quantity of pharmaceutically acceptable hydrophilic polymer (e.g. poly (vinyl) alcohol). This mitigates aggregation of the particles of active agent, which otherwise limits the desirable find particles dose available.
    Type: Application
    Filed: December 26, 2002
    Publication date: August 14, 2003
    Inventors: Gary Peter Martin, Xian Ming Zeng
  • Publication number: 20030118514
    Abstract: Elongated drug, especially salbutamol sulphate, and/or carrier particles, especially lactose, pharmaceutical compositions comprising the same, and use of the elongated particles in the manufacture of a medicament for the treatment of respiratory disease.
    Type: Application
    Filed: August 26, 2002
    Publication date: June 26, 2003
    Applicant: Glaxo Wellcome Inc.
    Inventors: El Hassane Larhrib, Christopher Marriott, Gary Peter Martin, John Nigel Pritchard, Xian Ming Zeng
  • Publication number: 20010005501
    Abstract: Pharmaceutical compositions comprising a mixture of hyaluronic acid and liposomes. Preferably, the pharmaceutical compositions further include a pharmaceutically active substance such as cyclosporin A encapsulated in the liposomes. A method for preparing a pharmaceutical composition includes producing liposomes from phospholipids, preferably in the presence of a pharmaceutically active substance (most preferably cyclosporin A) to be encapsulated within the liposomes, and mixing the liposomes with hyaluronic acid. Pharmaceutical compositions of this invention are used, for example, to topically administer pharmaceutical agents effective to treat skin disorders by deposition of that agent in the dermis or sub-dermis while minimizing systemic circulation thereof. These compositions are also administered orally, parenterally and intrarectally.
    Type: Application
    Filed: June 28, 1999
    Publication date: June 28, 2001
    Inventors: CHRISTOPHER MARRIOTT, GARY PETER MARTIN, MARK BARRY BROWN
  • Patent number: 5975076
    Abstract: A dry powder inhaler is provided which comprises a reservoir of medicament powder, a dispensing chamber for receiving a charge of powder to be dispensed having a floor upon which the powder charge lies prior to inhalation, an inlet passage having at its outlet end a nozzle protruding into the dispensing chamber directed toward the floor thereof and an inhalation passage exiting from the chamber through which the powder may be inhaled entrained in air drawn into the inhaler through the air inlet passage. The inhalation passage has an inlet at the dispensing chamber and an outlet through which the powder may be inhaled and comprises a first upstream portion having a roof and a floor both of which rise progressively with respect to a straight line drawn form the center of the inlet to the center of the outlet ad a second portion having a roof and a floor both of which fall progressively with respect to the line in the downstream direction.
    Type: Grant
    Filed: October 10, 1996
    Date of Patent: November 2, 1999
    Assignee: King's College London
    Inventors: Michael Yianneskis, Gary Peter Martin, Christopher Marriott, Kwok-On Suen, Ka-lok Carroll Lee, David Ganderton, Mukunda Timsina